Real-world use of seladelpar in adults with primary biliary cirrhosis
Collects everyday treatment data from adults with primary biliary cirrhosis taking seladelpar.
Plain-language title generated from the registry record
Registry title: Clinical Characterization of Patients With Primary Biliary Cirrhosis Treated With Seladelpar in the Real-life Setting
Key facts
- Where
- Berlin, Frankfurt, Hamburg, Hanover, Heidelberg, Herne, Homburg, Jena, Kiel, Leipzig, Leverkusen, Lübeck, München, Münster, Nuremberg, Tübingen, and Wiesbaden, GermanySee the 20 sites
Where in Germany
- Charité - Universitätsmedizin Berlin Med. Klinik für Gastroenterologie, Infektiologie und Rheumatologie (CBF)Berlin, GermanyNo longer taking part
- DRK Kliniken Berlin Mitte Klinik für Innere Medizin - Gastroenterologie, Hepatologie, Diabetologie, Angiologie und AbhängigkeitserkrankungenBerlin, GermanyNo longer taking part
- Universitätsklinikum Frankfurt Medizinische Klinik I, Haus 11/GastroenterologieFrankfurt, GermanyNo longer taking part
- Asklepios Klinik St. Georg, Leberzentrum, IFI-InstitutHamburg, GermanyNo longer taking part
- Klinik für Gastroenterologie, Hepatologie und Endokrinologie; Medizinische Hochschule HannoverHanover, GermanyNo longer taking part
- Universitätsklinikum Heidelberg; Medizinische Universitätsklinik Heidelberg, Innere Medizin IVHeidelberg, GermanyNo longer taking part
- Gastroenterologische Gemeinschaftspraxis Dres. Felten/Hinz/Mittrop/Sandmann/WallnerHerne, GermanyNo longer taking part
- Universitätsklinikum des Saarlandes, Klinik für Innere Medizin II, Gastroenterologie und EndokrinologieHomburg, GermanyNo longer taking part
- Universitätsklinikum Jena; Klinik für Innere Medizin IV - Gastroenterologie, Hepatologie, InfektiologieJena, GermanyNo longer taking part
- GHZ - gastroenterologisch - hepatologisches MVZ Kiel GmbHKiel, GermanyNo longer taking part
- Universitätsklinikum Schleswig-Holstein; Campus Kiel Klinik für Innere Medizin I - Gastroenerologie, HepatologieKiel, GermanyNo longer taking part
- Leipzig University, University Hospital Division of Hepatology, Department of Medicine II, Leipzig University Medical CenterLeipzig, GermanyNo longer taking part
- MVZ Gastroenterologie Leverkusen GbRLeverkusen, GermanyNo longer taking part
- Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Medizinische Klinik ILübeck, GermanyNo longer taking part
- Klinikum rechts der Isar der TU München, Medizinische Klinik und Poliklinik IIMünchen, GermanyNo longer taking part
- LMU Klinikum, Leber Centrum München (LCM), Campus GroßhadernMünchen, GermanyNo longer taking part
- Universitätsklinikum Münster, Medizinische Klinik BMünster, GermanyNo longer taking part
- Klinikum Nürnberg NordNuremberg, GermanyNo longer taking part
- Universitätsklinikum Tübingen, Medizinische Klinik ITübingen, GermanyNo longer taking part
- St. Josefs Hospital; Med. Klinik II: Gastroenterologie, HepatologieWiesbaden, GermanyNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Leipzig
- Trial code
- NCT07549607
- Record updated
- 24 April 2026
- Original description
The seladelpar registry will collect real-world data of patients with PBC diagnosis treated with seladelpar in the real-life scenario in Germany and Switzerland.Read full original descriptionShow less
Clinical Characterization of Patients With Primary Biliary Cirrhosis Treated With Seladelpar in the Real-life Setting
The seladelpar registry will collect real-world data of patients with PBC diagnosis treated with seladelpar in the real-life scenario in Germany and Switzerland.
Inclusion: Age ≥ 18 years; Diagnosis of PBC according to EASL criteria; Treatment with seladelpar; Written informed consent.
Exclusion: current or previous participation in a phase I to IV interventional clinical trial for seladelpar treatment of PBC; Pregnancy and breastfeeding.